Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Clindamycin (clindamycin systemic) is a member of the drug class lincomycin derivatives and is used to treat Aspiration Pneumonia, Babesiosis, Bacteremia, Bacterial Endocarditis Prevention, Bacterial Infection, Bacterial Vaginitis, Bone infection, Deep Neck Infection, Diverticulitis, Intraabdominal Infection, Joint Infection, Lemierre's Syndrome, Malaria, Pelvic Inflammatory Disease, Peritonitis, Pneumocystis Pneumonia, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Sinusitis, Skin or Soft Tissue Infection, Surgical Prophylaxis, Toxoplasmosis and Toxoplasmosis - Prophylaxis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Lincomycin

Chemical Names

L-treo-α-D-galacto-Octopyranoside, metyl 7-chloro-6,7,8-trideoxy-6-[[(1-metyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-tio-, (2S-trans)-

Metyl 7-chloro-6,7,8-trideoxy-6-trans-(1-metyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-tio-L-treo-α-D-galacto-octopyranoside (WHO)

Foreign Names

Generic Names

  • Clindamicina (OS: DCIT)
  • Clindamycin (OS: BAN, USAN)
  • Clindamycine (OS: DCF)
  • Chlorodeoxylincomycin (IS)
  • Chlorolincomycin (IS)
  • U 21251 (IS)
  • Clindamycin (PH: USP 41)
  • Clindamycin Phosphate (OS: USAN, BANM, JAN)
  • U 28508 (Upjohn) (IS)
  • Clindamycin Phosphate (PH: BP 2018, JP XVII, Ph. Int. 7, USP 41)
  • Clindamycin phosphate (PH: Ph. Eur. 9)
  • Clindamycin-2-dihydrogenphosphat (PH: Ph. Eur. 9)
  • Clindamycine (phosphate de) (PH: Ph. Eur. 9)
  • Clindamycini phosphas (PH: Ph. Eur. 9, Ph. Int. 7)
  • Clindamycin Hydrochloride (OS: BANM, JAN)
  • CDL 7 (IS)
  • Clinimycin hydrochloride (IS)
  • Clindamycin hydrochloride (PH: Ph. Eur. 9.3, Ph. Int. 7)
  • Clindamycin Hydrochloride (PH: BP 2018, JP XVII, Ph. Int. 7, USP 41)
  • Clindamycine (chlorhydrate de) (PH: Ph. Eur. 9.3, Ph. Int. 7)
  • Clindamycinhydrochlorid (PH: Ph. Eur. 9.3, Ph. Int. 7)
  • Clindamycini hydrochloridum (PH: Ph. Eur. 9.3, Ph. Int. 7)
  • U 21251 (IS)
  • UNII-ZNC153389R (IS)
  • Clindamycin Palmitate Hydrochloride (OS: BANM, USAN, JAN)
  • U 25179 E (Upjohn) (IS)
  • Clindamycin Palmitate Hydrochloride (PH: BP 1999, USP 41)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.